Details for: CL0002010

Cell ID: CL0002010

Cell Name: pre-conventional dendritic cell

Description: A lin-negative, MHC-II-negative, CD11c-positive, FLT3-positive cell with intermediate expression of SIRP-alpha.

Selected Context(s): Overall

Gene Significance Landscape

Display Options
Score:
Display
Genes

Contexts:

Cell Significance Index (CSI) is uniquely calculated to reveal cell-specific gene markers. More info here

Significant Genes List

Genes with the highest and lowest Percentile Rank Scores (PRS) for pre-conventional dendritic cell within the selected context(s).

Gene ID: A unique numerical identifier for this specific gene.
Symbol: Shortened abbreviation or name that represents this gene.
Ensembl Gene ID: A unique identifier assigned by Ensembl for genomic data mapping.
CSI Score: A combined effect size and statistical significance measure for pre-conventional dendritic cell. Higher scores indicate a stronger, more significant difference in expression.
(Previously described as "Fold Change", but now represents Cliff's Delta × –log10(p).)

Gene ID: A unique numerical identifier for this specific gene.
Symbol: Shortened abbreviation or name that represents this gene.
Ensembl Gene ID: A unique identifier assigned by Ensembl for genomic data mapping.
CSI Score: A combined effect size and statistical significance measure for pre-conventional dendritic cell. Higher scores indicate a stronger, more significant difference in expression.
Average CSI: csi sum / gene count
Cell network configuration

This network visualizes key genes for pre-conventional dendritic cell. It primarily includes:
1. Top genes highly significant for this cell (Num. Top Cell Genes - based on the 'Min. CSI' setting).
2. Any additional specific 'Context Genes' you add below.
The final network is a combined view. Choose an Interaction Source (pathways or protein interactions) and optionally compare CSI scores with a Baseline Cell Type.

Maximum number of selected genes.
Select a context for the baseline cell.
Select a context for the target cell.
Target Cell for CSI:  pre-conventional dendritic cell (CL0002010)

 Legend
Nodes (Genes):
 Query Gene
Node size also reflects Target Cell CSI magnitude.
Node Color (Target Cell CSI in specific network):
 Very High
 High
 Medium
 Low
 Very Low
 N/A or Not Sig.
Edges (Interactions):
 STRING (Protein-Protein)
 ONTOLOGY (Shared Pathway)
 Colors vary by pathway category; default arrow applies.

Loading network (please wait)...

## Summary The [pre-conventional dendritic cell](/details-cell/CL0002010) is a hematopoietic progenitor defined phenotypically as a lin-negative, MHC-II-negative, [CD11c](/details-gene/915)-positive, and [FLT3](/details-gene/2322)-positive cell. Based on its gene significance profile, this cell's identity is uniquely characterized by a high and specific expression of genes controlling fundamental cellular processes, including cytoskeletal organization, transcription, and protein synthesis. The top marker, [CFL1](/details-gene/1072), an actin-depolymerizing factor, suggests that cellular motility and structural plasticity are paramount at this developmental stage. This transcriptional signature is consistent with a cell metabolically primed for rapid differentiation, migration, and response to developmental cues, rather than one expressing specialized immune effector functions. ## Key Characteristics and Function **Overall**, the gene expression landscape of the [pre-conventional dendritic cell](/details-cell/CL0002010) is dominated by genes essential for core cellular biology, as indicated by their high specificity (`csi_z`) scores. These markers can be grouped into several key functional clusters. * **Transcriptional and Post-Transcriptional Regulation:** A prominent feature of this cell is the highly specific expression of numerous RNA and DNA binding proteins. This includes the general transcription factor [BTF3](/details-gene/689), heterogeneous nuclear ribonucleoproteins ([HNRNPA2B1](/details-gene/3181), [HNRNPC](/details-gene/3183)), the RNA-binding protein [YBX1](/details-gene/4904), and the poly(A)-binding protein [PABPC1](/details-gene/26986). This pattern suggests that the cell maintains a state of high transcriptional activity and complex post-transcriptional regulation, likely necessary to control the precise gene expression programs required for its subsequent differentiation into various dendritic cell subsets. * **Protein Synthesis and Metabolism:** The cell exhibits a strong signature of high translational capacity, marked by the specific expression of translation elongation factors [EEF1B2](/details-gene/1933) and [EEF1D](/details-gene/1936). This is complemented by markers for energy metabolism, such as [GAPDH](/details-gene/2597) and the cytochrome c oxidase subunit [COX7C](/details-gene/1350), indicating a high metabolic rate to fuel the energetic demands of proliferation and differentiation. * **Cytoskeletal and Chromatin Dynamics:** The top marker, [CFL1](/details-gene/1072), is critical for actin filament dynamics, pointing to the importance of cell motility, migration, and morphological changes in this progenitor state. Furthermore, high significance for chromatin-associated proteins like nucleosome assembly protein [NAP1L1](/details-gene/4673), histone variant [H2AZ1](/details-gene/3015), and the damage-associated molecular pattern (DAMP) protein [HMGB1](/details-gene/3146) suggests that chromatin accessibility and remodeling are key regulatory features. The identity of the [pre-conventional dendritic cell](/details-cell/CL0002010) is also sharpened by its anti-markers. The low significance of the granulocyte colony-stimulating factor receptor ([CSF3R](/details-gene/1441)), myeloperoxidase ([MPO](/details-gene/4353)), and the mature dendritic cell marker [CD83](/details-gene/9308) confirms its undifferentiated state and distinctness from mature granulocytic or dendritic lineages. Similarly, the lack of specific expression for potent inflammatory cytokines like [IL1B](/details-gene/3553) or key chemokine receptors like [CXCR4](/details-gene/7852) underscores its role as a progenitor not yet committed to a specific effector immune response. ## Clinical Significance and Contextual Roles Given that the analysis is performed in an **Overall** context without a direct disease comparison, the clinical significance must be inferred from the nature of the top marker genes. The profile suggests a cell state that could be vulnerable to dysregulation in hematologic disorders. The high expression of [NPM1](/details-gene/4869), a nucleolar phosphoprotein involved in ribosome biogenesis and chromatin remodeling, is notable. Mutations in [NPM1](/details-gene/4869) are among the most common genetic alterations in acute myeloid leukemia (AML), suggesting that dysregulation of the core cellular processes highlighted in this progenitor cell could be a step towards malignant transformation. Similarly, [HMGB1](/details-gene/3146) is a well-known alarmin released by necrotic cells that can promote inflammation and tumor progression. Its specific expression in this progenitor cell may indicate a role in sensing tissue damage to initiate dendritic cell differentiation, a process that could be co-opted in cancer. The strong signature of genes involved in RNA processing and translation ([HNRNPA2B1](/details-gene/3181), [YBX1](/details-gene/4904), [PABPC1](/details-gene/26986)) also points to potential vulnerabilities. Alterations in the splicing and translation machinery are increasingly recognized as drivers of various cancers. Therefore, the specific reliance of [pre-conventional dendritic cells](/details-cell/CL0002010) on this machinery may represent a point of failure leading to aberrant development or function in pathological states. ## Potential Mechanisms and Research Directions 1. **Hypothesis:** The defining characteristic of the [pre-conventional dendritic cell](/details-cell/CL0002010) is not the expression of a unique immune receptor, but a state of "primed potential" maintained by the unusually high and specific expression of core transcriptional, translational, and metabolic machinery. This elevated basal activity enables the cell to respond rapidly and robustly to differentiation signals like FLT3L, committing to a specific mature dendritic cell fate more efficiently than other progenitors. * **Surprising Findings:** The most specific gene markers for this immune progenitor are not classical immune-related genes but are instead fundamental "housekeeping" genes. This challenges the conventional marker discovery paradigm and suggests that the *level* of core machinery expression is itself a key determinant of cell identity at this stage. * **Testable Questions:** If [pre-conventional dendritic cells](/details-cell/CL0002010) are treated with low-dose inhibitors of transcription (e.g., actinomycin D) or translation (e.g., cycloheximide), is their differentiation into [conventional dendritic cells](/details-cell/CL0000451) disproportionately impaired compared to other myeloid progenitors like common myeloid progenitors (CMPs)? 2. **Hypothesis:** The high specific expression of the actin-remodeling protein [CFL1](/details-gene/1072) and the chromatin-architectural protein [HMGB1](/details-gene/3146) reflects a critical axis governing the cell's migratory capacity and developmental plasticity. [CFL1](/details-gene/1072)-driven cytoskeletal dynamics may be essential for their mobilization from bone marrow, while [HMGB1](/details-gene/3146) may function to maintain a plastic chromatin state, allowing for large-scale transcriptional changes during maturation in peripheral tissues. * **Surprising Findings:** An actin-binding protein, [CFL1](/details-gene/1072), is the single most specific marker for this cell type. This finding elevates the importance of cell motility and morphology as a primary characteristic of this progenitor, potentially outweighing its surface marker profile in defining its biological state. * **Testable Questions:** Does conditional knockout of [CFL1](/details-gene/1072) in the hematopoietic compartment lead to a specific reduction of conventional dendritic cells in peripheral lymphoid organs, suggesting a defect in egress or tissue homing of the precursor population?